No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
102 |
4. Check minimum number of eventsNone |
102 |
5. Include endpointsNone |
102 |
6. Filter based on genotype QC (FinnGen only) |
98 |
Control definitions (FinnGen only)
- Control exclude
- AB1_HELMINTIASES
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF13
Similar endpoints
↥List of similar endpoints to
Intestinal helminthiases, other/unspecified
based on the number of shared cases.
Similar with more cases:
- Helminthiases
- Certain infectious and parasitic diseases
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 98 | 56 | 42 |
| Unadjusted period prevalence (%) | 0.02 | 0.02 | 0.02 |
| Median age at first event (years) | 67.89 | 66.88 | 69.25 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 102
- Matched controls
- 1020
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
B81
ICPC
Anaemia vit B12/folate deficiency
116.4
121.7
69
18
B03BA03
ATC
hydroxocobalamin; parenteral
66.7
103.2
69
31
B81
ICD-10 Finland
Other intestinal helminthiases, not elsewhere classified
+∞
90.6
73
*
107
Kela drug reimbursment
Pernicious anaemia
109.6
29.7
31
*
SPAT1336
SPAT
Request for examination
28.8
25.8
35
18
T91
ICPC
Vitamin/nutritional deficiency
76.1
25.6
28
5
L28
ICPC
Limited function/disability (L)
7.8
24.5
53
124
A98
ICD-10 Finland
Other viral haemorrhagic fevers, not elsewhere classified
51.6
23.1
27
7
A97
ICPC
No disease
7.1
21.4
48
114
K29.4
ICD-10 Finland
Chronic atrophic gastritis
36.2
19.9
25
9
S50
ICPC
Skin, Medication/prescr/renewal
123.0
19.3
20
*
EB1AA, ,
SPAT
9.7
18.7
25
33
Z2221
NOMESCO Finland
Medical doctor
6.0
18.4
60
197
SPAT1212
SPAT
Extensive examination of musculoskeletal system
8.4
17.1
26
40
A48
ICPC
General and Unspecified, Clarification/discussion RFE/demand
15.6
16.9
28
24
B50
ICPC
Blood and Immunity, Medication/prescr/renewal
101.0
16.1
17
*
A99
ICPC
Disease/condition unspecnature/site
6.9
16.0
30
58
B81.8
ICD-10 Finland
Other specified intestinal helminthiases
+∞
14.9
14
*
ZXD10
NOMESCO Finland
Scheduled procedure
5.1
14.5
67
279
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
6.0
13.9
30
66
R4110
NOMESCO Finland
Physiotherapy
4.7
13.7
55
203
WX110, ,
SPAT
11.5
12.3
23
25
B60
ICPC
Blood and Immunity, Result test/procedure
53.5
12.2
14
*
D51.0
ICD-10 Finland
Vitamin B12deficiency anaemia due to intrinsic factor deficiency
53.5
12.2
14
*
Z3226
NOMESCO Finland
Physiotherapist
4.6
12.1
39
120
A60
ICPC
General and Unspecified, Result test/procedure
11.1
12.1
23
26
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
4.8
11.9
35
100
T45
ICPC
Metabolic, Observ/health educat/advice/diet
21.7
10.6
15
8
EB1SA, ,
SPAT
15.4
10.6
17
13
D06
ICPC
Abdominal pain localized other
5.8
10.1
21
44
ZXE00
NOMESCO Finland
One hour or less
3.8
9.9
63
305
K43
ICPC
Cardiovascular, Other diagnostic procedure
24.5
9.6
13
6
S56
ICPC
Skin, Dressing/pressure/compress/tamponade
109.8
9.6
10
*
L17
ICPC
Foot/toe symptom/complaint
3.6
9.5
50
213
T31
ICPC
Metabolic, Medical examin/health eval partial
40.6
9.2
11
*
XF400
NOMESCO Finland
ECG with 12 standard connections
4.0
9.0
33
109
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
3.8
9.0
37
133
A50
ICPC
General and Unspecified, Medication/prescr/renewal
13.3
8.9
15
13
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
4.0
8.9
33
110
WX002
NOMESCO Finland
Sedation and analgesia
3.7
8.7
37
135
R05
ICPC
Cough
3.6
8.7
42
167
T69
ICPC
Metabolic, Other reason for encounter NEC
24.4
8.2
11
5
Z3231
NOMESCO Finland
Registered nurse
3.3
8.1
48
215
WX404
NOMESCO Finland
Intravenous generell anesthesy
3.6
8.0
35
130
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.3
7.8
67
372
S29
ICPC
Skin symptom/complaint other
3.5
7.8
36
138
SPAT1342
SPAT
Referral to specialised care
27.4
7.7
10
*
ZXE10
NOMESCO Finland
More than one and less than three hours
3.2
7.6
54
267
K02.0
ICD-10 Finland
Caries limited to enamel
3.9
7.5
27
87
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
6.6
7.5
19
34
D62
ICPC
Digestive, Administrative procedure
86.1
7.5
8
*
A28
ICPC
Limited function/disability NOS
3.5
7.4
32
117
B81.4
ICD-10 Finland
Mixed intestinal helminthiases
+∞
7.4
7
*
L17, ,
ICD-10 Finland
+∞
7.4
7
*
F43
ICPC
Eye, Other diagnostic procedure
21.9
7.3
10
5
D13.1
ICD-10 Finland
Benign neoplasm: Stomach
15.2
7.1
11
8
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
8.8
6.9
14
18
WVA20, ,
SPAT
13.5
6.8
11
9
A62
ICPC
General and Unspecified, Administrative procedure
11.1
6.7
12
12
L02
ICPC
Back symptom/complaint
4.3
6.7
19
51
R06.0
ICD-10 Finland
Dyspnoea
3.0
6.6
44
207
R48
ICPC
Respiratory, Clarification/discussion RFE/demand
74.3
6.5
7
*
WZB00, ,
SPAT
4.7
6.4
16
39
A08
ICPC
Swelling
4.7
6.4
16
39
N43
ICPC
Neurological, Other diagnostic procedure
+∞
6.3
6
*
SPAT1249
SPAT
Treatment-related counselling outside office
0.2
6.2
8
300
ZXE20
NOMESCO Finland
More than three and less than five hours
3.3
6.0
27
100
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
55
143
7.18
22.57
2.5
3.3
1.17
3.00
e6/l
1.00
12
76
38
70
8.06
21.72
3.4
2.8
28.12
27.10
u/l
0.11
32
58
52
149
6.08
18.64
2.5
3.0
0.44
1.19
e6/l
—
9
81
62
265
4.42
12.41
3.0
3.2
0.25
0.40
e6/l
0.41
32
191
74
372
4.60
11.57
3.2
2.1
94.22
92.73
pmol/l
0.10
39
179
39
127
4.35
11.12
2.3
2.5
19.76
21.23
%
0.28
39
113
69
338
4.22
10.99
3.2
3.2
—
—
—
0
0
39
134
4.09
10.24
2.3
2.5
2.51
2.35
g/l
0.78
39
117
20
40
5.98
10.05
4.8
3.7
24.35
24.52
mmol/l
0.08
20
40
43
161
3.89
9.95
3.6
3.1
1313.38
84.00
ng/l
0.79
32
128
41
149
3.93
9.90
2.3
2.3
13.05
12.26
umol/l
0.25
41
134
50
221
3.48
8.79
2.4
2.1
2.90
3.11
mg/l
0.22
43
189
93
716
4.38
5.88
27.5
18.5
14.98
15.27
%
0.21
93
711
29
115
3.13
5.77
4.4
4.7
0.97
1.01
mmol/l
0.38
29
105
46
239
2.68
5.53
1.4
1.6
1.39
1.28
mmol/l
0.49
46
203
96
781
4.89
5.12
24.2
15.0
79.61
76.95
ml/min/173m2
0.51
73
639
12
22
6.03
4.77
2.2
1.2
—
—
—
0
0
43
241
2.36
4.17
2.6
1.6
19.65
20.50
nmol/l
0.18
43
196
26
117
2.64
4.00
9.6
6.6
103.12
103.73
mmol/l
0.18
26
117
15
49
3.42
3.99
1.4
1.6
—
—
—
0
0
14
38
4.10
3.98
4.5
2.5
142.36
4346.67
u/ml
0.60
14
33
21
85
2.85
3.94
4.7
3.3
1.38
2.35
mmol/l
0.45
21
68
37
199
2.35
3.90
2.3
2.0
—
—
—
0
0
19
80
2.69
3.30
3.3
2.5
0.22
0.20
g/l
0.24
19
72
22
103
2.45
3.09
1.8
1.7
—
—
—
0
0
5
5
10.42
3.01
1.2
1.0
14.40
18.00
u/l
—
5
5
8
17
5.01
2.98
1.8
1.5
—
—
—
0
0
8
17
5.01
2.98
1.8
1.5
—
—
—
0
0
95
829
3.12
2.80
21.1
15.4
29.28
25.31
mg/l
0.56
80
676
67
506
1.94
2.56
10.6
8.7
4.33
4.24
e9/l
0.13
44
442
19
340
0.46
2.46
3.2
4.3
—
—
—
0
0
5
8
6.50
2.40
1.8
1.1
136.00
394.20
u/l
—
5
8
5
8
6.50
2.40
1.0
1.0
—
—
—
0
0
26
145
2.06
2.40
1.9
1.8
—
—
—
0
0
15
67
2.45
2.31
2.9
1.9
530.40
126.46
ng/l
0.68
15
59
7
18
4.09
2.29
1.7
1.1
—
—
—
0
0
7
19
3.87
2.19
1.1
1.2
—
—
—
0
0
13
57
2.47
2.07
6.0
6.6
24.77
25.06
mmol/l
0.09
13
57
20
107
2.08
2.04
1.8
1.7
—
—
—
0
0
5
11
4.72
1.96
2.6
3.3
—
—
—
0
0
19
102
2.06
1.92
3.8
4.2
1.78
51.55
ug/l
0.64
14
85
17
292
0.50
1.86
4.1
2.3
62.76
55.50
u/l
0.47
17
266
57
436
1.70
1.84
11.6
14.8
1.06
1.25
inr
—
5
145
59
459
1.68
1.76
3.0
2.7
—
—
—
0
0
5
13
3.99
1.73
2.4
2.5
11.80
3.05
nmol/l
—
5
13
70
793
0.63
1.30
3.6
4.2
1.44
1.22
mmol/l
1.20
70
708
5
19
2.71
1.23
1.2
1.3
—
2.58
—
0
5
5
19
2.71
1.23
1.0
1.2
—
—
—
0
0
11
57
2.04
1.22
1.7
1.3
—
—
—
0
0
9
45
2.09
1.08
3.2
1.5
9.02
10.23
g/l
—
9
40
9
47
2.00
1.05
3.2
1.5
—
—
—
0
0
6
30
2.06
0.88
1.5
1.8
—
—
—
0
0
6
30
2.06
0.88
1.5
1.8
—
—
—
0
0
13
82
1.67
0.83
4.3
3.2
78.23
74.78
ng/l
0.11
13
75
26
194
1.46
0.82
2.2
1.6
1.52
1.27
mg/l
0.22
21
150
0
26
0.00
0.79
0.0
1.5
—
—
—
0
0
0
27
0.00
0.78
0.0
2.7
—
105.99
—
0
17
60
524
1.35
0.74
6.8
4.5
6.92
6.66
mmol/l
0.43
60
486
0
20
0.00
0.61
0.0
1.4
—
—
—
0
0
46
401
1.27
0.52
2.4
2.4
—
—
—
0
0
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
0
15
0.00
0.41
0.0
1.4
—
—
—
0
0
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
0
16
0.00
0.41
0.0
1.4
—
—
—
0
0
0
17
0.00
0.41
0.0
1.7
—
—
—
0
0
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
0
19
0.00
0.39
0.0
1.3
—
—
—
0
0
6
44
1.39
0.35
1.2
2.4
4.00
1.20
%
—
6
44
7
56
1.27
0.30
2.1
3.5
0.13
0.06
e6/l
—
7
56
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
2.2
—
4.20
—
0
5
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
12
0.00
0.21
0.0
1.5
—
—
—
0
0
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
18
157
1.18
0.19
2.5
3.4
0.60
0.76
ug/l
0.71
11
115
9
79
1.15
0.16
1.0
2.0
1.73
1.74
%
—
9
65
20
216
0.91
0.09
2.8
4.9
25.13
20.74
%
—
6
119
5
61
0.81
0.08
1.4
1.7
—
—
—
0
0
11
122
0.89
0.07
1.3
1.4
—
—
—
0
0
29
276
1.07
0.07
3.4
4.0
5.11
8.29
mg/mmol
0.61
19
180
10
108
0.92
0.03
2.1
3.8
—
—
—
0
0
12
124
0.96
0.00
1.9
1.6
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
8.2
—
230.80
—
0
5
0
9
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
6.2
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.4
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
2.7
—
—
—
0
0
0
6
0.00
-0.00
0.0
2.7
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: AB1_INT_HELMINTIASES_NOS_WIDE – Intestinal helminthiases, other/unspecified
GWS hits: -
This endpoint is excluded (different definition than used in FinnGen).